Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokion’s distinct approach leverages the company’s immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease.
Company Details
- Employees
- 16
- Address
- 50 Hampshire St, Cambridge,massachusetts 02139,united States
- in****@****ion.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- anokion.com
- HQ
- Cambridge, Massachusetts
Anokion Questions
Anokion's website is anokion.com
Anokion's LinkedIn profile is https://www.linkedin.com/company/anokion-sa
Anokion has
16 employees.
View email and phone details for 16
employees at Anokion.
Anokion's industry is
Biotechnology Research
Anokion's top competitors are
Cour Pharma,
Ac Immune,
Light Chain Bioscience | Novimmune Sa,
Gentibio,
Radiant Biotherapeutics,
Asceneuron Sa,
Diamyd Medical,
Genentech,
Addex Therapeutics,
Amal Therapeutics.
Anokion's support email address is info@anokion.com
Anokion's categories are Biotechnology Research
